We are live on ! Find out more
CCM

Camber Capital Management Portfolio holdings

AUM $1.07B
1-Year Est. Return 8.19%
This Fund
S&P 500
This Quarter Est. Return
+13.63%
1 Year Est. Return
-8.19%
3 Year Est. Return
+26.6%
5 Year Est. Return
+54.57%
10 Year Est. Return
+164.72%
AUM
$2.92B
AUM Growth
-$350M
Cap. Flow
-$566M
Cap. Flow %
-19.43%
Top 10 Hldgs %
63.81%
Holding
52
New
7
Increased
11
Reduced
10
Closed
13

Top Buys

Rank Stock Value
1
WBA
Walgreens Boots Alliance
WBA
+$81.8M
2
THC icon
Tenet Healthcare
THC
+$46.2M
3
GSK icon
GSK
GSK
+$41.6M
4
MYGN icon
Myriad Genetics
MYGN
+$37.3M
5
ALGN icon
Align Technology
ALGN
+$35M

Top Sells

Rank Stock Value
1
VTRS icon
Viatris
VTRS
+$105M
2
CRL icon
Charles River Laboratories
CRL
+$98.4M
3
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$67.8M
4
UHS icon
Universal Health Services
UHS
+$64.9M
5
CHNG
Change Healthcare Inc. Common Stock
CHNG
+$63.9M

Sector Composition

Rank Sector Weight
1 Healthcare 96.56%
2 Consumer Discretionary 0.54%
3 Technology 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
OSH
51
DELISTED
Oak Street Health, Inc.
OSH
– –
-506,000
Closed -$12.4M
CHNG
52
DELISTED
Change Healthcare Inc. Common Stock
CHNG
– –
-2,325,000
Closed -$63.9M
1 2
3

Similar funds

PP
PrairieView Partners St. Paul, Minnesota $1.03B AUM 11.4% 1-Year Est. Return
SAF
Smith Anglin Financial Dallas, Texas $1.1B AUM 14.08% 1-Year Est. Return
NRD
Nebula Research & Development New York $1.17B AUM 15.19% 1-Year Est. Return
FC
Forte Capital Rochester, New York $930M AUM 24.11% 1-Year Est. Return
GIM
Grassi Investment Management Santa Clara, California $1.26B AUM 23.4% 1-Year Est. Return
SC
Savoie Capital Chicago, Illinois $805M AUM 19.48% 1-Year Est. Return
BWA
Bordeaux Wealth Advisors Menlo Park, California $781M AUM 26.55% 1-Year Est. Return
CCP
Camelot Capital Partners Laguna Beach, California $686M AUM 163.55% 1-Year Est. Return

Camber Capital Management's Q4 2022 Portfolio in Review

As of Q4 2022, Camber Capital Management held 52 positions worth $2.92B, down 11% from $3.27B the previous quarter. Its ten largest holdings account for 64% of the portfolio.

Camber Capital Management withdrew a net $566M in Q4 2022, closing 13 positions and reducing 10 holdings. Its most notable exit was Charles River Laboratories, an estimated $98.4M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 97% of assets, up from 88% a quarter earlier, followed by Consumer Discretionary and Technology.

Against the trend, Camber Capital Management opened a new position in Qiagen worth $37.4M.

  • Camber Capital Management's largest Q4 2022 buy was Qiagen: 707,292 shares worth $37.4M.
  • Camber Capital Management added most to Walgreens Boots Alliance in Q4 2022, an estimated $81.8M increase.
  • Camber Capital Management's biggest Q4 2022 reduction was Viatris, cutting an estimated $105M.
  • Camber Capital Management fully exited Charles River Laboratories in Q4 2022, selling an estimated $98.4M.
  • Camber Capital Management's ten largest holdings make up 64% of its $2.92B portfolio in Q4 2022.
  • Camber Capital Management opened 7 new positions and closed 13 in Q4 2022.
  • Camber Capital Management's portfolio value fell 11% quarter-over-quarter to $2.92B.

Based on Camber Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.